Company / Working Capital
Arcturus Therapeutics Holdings Inc. Working Capital History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$205.1M
FY2025
5-year range
$205.1M / $304.6M
FY2021-FY2025
Trend
-14.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 7 years, ranging from $53M in FY2019 to $418M in FY2020.
Based on SEC 10-K filings.
$205M in FY2025 with a 5-year CAGR of -13.3%.
Declined from $305M to $205M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -9.5%
- 5-Year CAGR
- -13.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -13.3%, indicating a declining trend.
- In FY2025, working capital decreased 14.7% year-over-year.
- Peak working capital was recorded in FY2020.
- Lowest working capital in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $205.1M | -14.7% |
| FY2024 | $240.5M | -21.0% |
| FY2023 | $304.6M | +10.2% |
| FY2022 | $276.3M | -1.1% |
| FY2021 | $279.4M | -33.2% |
| FY2020 | $418.3M | +689.7% |
| FY2019 | $53.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026